$1.42
-0.05-3.40%
At close: Jun 4, 5:00 PM EST
$1.49
0.021.36%
Pre-Market: 4:09 AM EST
Boundless Bio Inc Earnings Estimates
BOLDNASDAQ
Boundless Bio Earnings Estimates, EPS & Revenue | NASDAQ:BOLD
Boundless Bio (BOLD) is scheduled to report Q2 earnings on August 4, 2026. Analysts estimate EPS of $-0.59 and quarterly revenue of N/A.
In the most recent quarter (Q1), Boundless Bio reported EPS of $-0.60, missing estimates of $-0.55 by 0.09%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Boundless Bio has missed EPS estimates in 4 consecutive quarters.
Over the last 4 quarters, Boundless Bio has averaged an EPS surprise of 0.10% and a revenue surprise of 0.00%.
Earnings Date
Aug 4
EPS Estimate
$-0.590
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Boundless Bio Earnings History
Analyze the earnings history of Boundless Bio using advanced sorting and filters.
Loading calendar...
Boundless Bio (BOLD) Earnings Per Share
The chart below shows Boundless Bio's reported EPS compared to analyst estimates over recent quarters.
Boundless Bio (BOLD) Revenue
The chart below shows Boundless Bio's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Boundless Bio (NASDAQ:BOLD) reporting earnings?
Boundless Bio (BOLD) is scheduled to report earnings on August 4, 2026. The last reported earnings were for reported on May 8, 2026 for Q1.
What were the latest earnings per share (EPS) for Boundless Bio (NASDAQ:BOLD)?
The Actual EPS was $-0.60, which missed the estimate of $-0.55.
What were Boundless Bio’s (NASDAQ:BOLD) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
